The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2107870
WO Application Number:
US2008001253
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP08713353.4
WO Publication Number:
WO2008094618
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
29/01/2008
Grant date:
27/01/2016
EP Publication Date:
14/10/2009
WO Publication Date:
07/08/2008
Claims Translations Received Date:
Claims Translation B1 Received Date:
06/04/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/02/2022
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
27/01/2016
EP B1 Publication Date:
27/01/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
28/01/2028
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
27/01/2016
Name:
Alaven Pharmaceutical, LLC
Address:
265 Davidson Avenue, Somerset, NJ 08873-4120, United States of America (US)
Domicile Holder
Name:
ir. J.D. de Zeeuw
From:
06/04/2016
Address:
Murgitroyd & Company
Scotland House 165 - 169 Scotland Street, G5 8PL, Glasgow, United Kingdom (GB)
To:
Inventor
1
Name:
VENKATARAMAN, Bala
Address:
Alpharetta, GA 30004, United States of America (US)